Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Intravenous iron for heart failure with evidence of iron deficiency: a meta-analysis of randomised trials
Fraser J Graham, Pierpaolo Pellicori, Ian Ford, et al.
Clinical Research in Cardiology (2021) Vol. 110, Iss. 8, pp. 1299-1307
Open Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial
Paul R. Kalra, John G.F. Cleland, Mark C. Petrie, et al.
The Lancet (2022) Vol. 400, Iss. 10369, pp. 2199-2209
Open Access | Times Cited: 256
Iron deficiency and cardiovascular disease
Gianluigi Savarese, Stephan von Haehling, Javed Butler, et al.
European Heart Journal (2022) Vol. 44, Iss. 1, pp. 14-27
Open Access | Times Cited: 120
Intravenous iron in patients with heart failure and iron deficiency: an updated meta‐analysis
Fraser J Graham, Pierpaolo Pellicori, Paul R. Kalra, et al.
European Journal of Heart Failure (2023) Vol. 25, Iss. 4, pp. 528-537
Open Access | Times Cited: 81
Inflammatory pathways in heart failure with preserved left ventricular ejection fraction: implications for future interventions
Nicola Riccardo Pugliese, Pierpaolo Pellicori, Francesco Filidei, et al.
Cardiovascular Research (2022) Vol. 118, Iss. 18, pp. 3536-3555
Open Access | Times Cited: 75
Iron Deficiency in Heart Failure: Mechanisms and Pathophysiology
Ridha I.S. Alnuwaysir, Martijn F. Hoes, Dirk J. van Veldhuisen, et al.
Journal of Clinical Medicine (2021) Vol. 11, Iss. 1, pp. 125-125
Open Access | Times Cited: 104
Micronutrient deficiencies in heart failure: Mitochondrial dysfunction as a common pathophysiological mechanism?
Nils Bömer, Mario Pávez, Niels Grote Beverborg, et al.
Journal of Internal Medicine (2022) Vol. 291, Iss. 6, pp. 713-731
Open Access | Times Cited: 44
Natural history and prognostic significance of iron deficiency and anaemia in ambulatory patients with chronic heart failure
Fraser J Graham, G Masini, Pierpaolo Pellicori, et al.
European Journal of Heart Failure (2021) Vol. 24, Iss. 5, pp. 807-817
Open Access | Times Cited: 49
Assessment of haemoglobin and serum markers of iron deficiency in people with cardiovascular disease
Fraser J Graham, Jocelyn Friday, Pierpaolo Pellicori, et al.
Heart (2023) Vol. 109, Iss. 17, pp. 1294-1301
Open Access | Times Cited: 14
Anaemia predicts iron homoeostasis dysregulation and modulates the response to empagliflozin in heart failure with reduced ejection fraction: the EMPATROPISM-FE trial
Christiane E. Angermann, Susanne Sehner, Louisa M.S. Gerhardt, et al.
European Heart Journal (2024)
Open Access | Times Cited: 5
Influence of serum transferrin concentration on diagnostic criteria for iron deficiency in chronic heart failure
Fraser J Graham, Pierpaolo Pellicori, G Masini, et al.
ESC Heart Failure (2023) Vol. 10, Iss. 5, pp. 2826-2836
Open Access | Times Cited: 12
Acute heart failure and iron deficiency: a prospective, multicentre, observational study
Dirk H. van Dalen, Johannes A. Kragten, Mireille E. Emans, et al.
ESC Heart Failure (2021) Vol. 9, Iss. 1, pp. 398-407
Open Access | Times Cited: 22
Safety and Efficacy of Intravenous Ferric Derisomaltose Compared to Iron Sucrose for Iron Deficiency Anemia in Patients with Chronic Kidney Disease With and Without Heart Failure
Andrew P. Ambrosy, Stephan von Haehling, Paul R. Kalra, et al.
The American Journal of Cardiology (2021) Vol. 152, pp. 138-145
Open Access | Times Cited: 21
Comparative efficacy of intravenous and oral iron supplements for the treatment of iron deficiency in patients with heart failure: A network meta-analysis of randomized controlled trials
Ziwei Mei, Jun Chen, Songmei Luo, et al.
Pharmacological Research (2022) Vol. 182, pp. 106345-106345
Closed Access | Times Cited: 15
Latest pharmaceutical approaches across the spectrum of heart failure
Dimitrios Bismpos, Jan Wintrich, Julian Hövelmann, et al.
Heart Failure Reviews (2024) Vol. 29, Iss. 3, pp. 675-687
Open Access | Times Cited: 3
Intravenous iron therapy among patients with heart failure and iron deficiency: An updated meta-analysis of randomized controlled trials
Mohamed Hamed, Sheref A. Elseidy, Asmaa Ahmed, et al.
Heliyon (2023) Vol. 9, Iss. 6, pp. e17245-e17245
Open Access | Times Cited: 7
Intravenous iron therapy for patients with iron deficiency and heart failure: a systematic review and meta-analysis of randomized controlled trials
Mohammed Mhanna, M. Sauer, Ahmad Al‐Abdouh, et al.
Baylor University Medical Center Proceedings (2024) Vol. 37, Iss. 3, pp. 466-476
Open Access | Times Cited: 2
Rationale and design of a randomised trial of intravenous iron in patients with heart failure
Paul R. Kalra, John G.F. Cleland, Mark C. Petrie, et al.
Heart (2022) Vol. 108, Iss. 24, pp. 1979-1985
Open Access | Times Cited: 11
Short-term treatment of iron deficiency anemia after cardiac surgery
Elio Venturini, Gabriella IANNUZZO, Anna DI LORENZO, et al.
IJC Heart & Vasculature (2022) Vol. 40, pp. 101038-101038
Open Access | Times Cited: 9
Cardiorenal syndrome and iron supplementation—more benefits than risks: a narrative review
Georgia Doumani, Georgios Spanos, Panagiotis Theofilis, et al.
International Urology and Nephrology (2023) Vol. 56, Iss. 2, pp. 597-606
Closed Access | Times Cited: 5
Preoperative Evaluation and Care of Heart Transplant Candidates
Nian Chih Hwang, Cumaraswamy Sivathasan
Journal of Cardiothoracic and Vascular Anesthesia (2022) Vol. 36, Iss. 11, pp. 4161-4172
Closed Access | Times Cited: 8
Prevalence and prognostic impact of chronic kidney disease and anaemia across ACC/AHA precursor and symptomatic heart failure stages
Louisa M.S. Gerhardt, Maren Kordsmeyer, Susanne Sehner, et al.
Clinical Research in Cardiology (2022) Vol. 112, Iss. 7, pp. 868-879
Open Access | Times Cited: 7
The Efficacy and Safety of Ferric Carboxymaltose in Heart Failure with Reduced Ejection Fraction and Iron Deficiency: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials
Inderbir Padda, Sneha Annie Sebastian, Daniel Fabián, et al.
Diseases (2024) Vol. 12, Iss. 12, pp. 339-339
Open Access | Times Cited: 1
Reply to the letter regarding the article ‘Natural history and prognostic significance of iron deficiency and anaemia in ambulatory patients with chronic heart failure’
Fraser J Graham, Pierpaolo Pellicori, John G.F. Cleland, et al.
European Journal of Heart Failure (2021) Vol. 23, Iss. 10, pp. 1800-1801
Open Access | Times Cited: 9
Clinical outcomes of intravenous iron therapy in patients with heart failure and iron deficiency: Meta-analysis and trial sequential analysis of randomized clinical trials
Kirtipal Bhatia, Basera Sabharwal, Kartik Gupta, et al.
Journal of Cardiology (2023) Vol. 83, Iss. 2, pp. 105-112
Closed Access | Times Cited: 3
Prévalence de la carence martiale dans une population de patients insuffisants rénaux chroniques non dialysés : étude nationale multicentrique observationnelle CARENFER
Gabriel Choukroun, Isabelle Kazes, Jacques Dantal, et al.
Néphrologie & Thérapeutique (2022) Vol. 18, Iss. 3, pp. 195-201
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top